Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Myfungin vs Mycamine in Healthy Volunteers
NCT05496725Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in invasive candidiasis, sponsored by Yung Shin Pharmaceutical Industry. Started Jan 2022; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT05496725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05496725.